UK markets open in 1 hour 58 minutes

Enliven Therapeutics, Inc. (ELVN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.47-0.37 (-1.69%)
At close: 04:00PM EDT
21.02 -0.45 (-2.10%)
After hours: 07:36PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
72,664
64,574
31,022
20,474
8,240
Selling general and administrative
20,434
18,955
7,769
4,288
1,078
Total operating expenses
93,098
83,529
38,791
24,762
9,318
Operating income or loss
-93,098
-83,529
-38,791
-24,762
-9,318
Total other income/expenses net
-
-22
-
-
-9,679
Income before tax
-79,598
-71,584
-37,662
-24,740
-18,966
Income from continuing operations
-79,598
-71,584
-37,662
-24,740
-18,966
Net income
-79,598
-71,584
-37,662
-24,740
-18,966
Net income available to common shareholders
-79,598
-71,584
-37,662
-24,740
-18,966
Basic EPS
-0.92
-2.01
-0.92
-0.60
-0.46
Diluted EPS
-0.92
-2.01
-0.92
-0.60
-0.46
Basic average shares
41,100
35,546
41,100
41,100
41,100
Diluted average shares
41,100
35,546
41,100
41,100
41,100